Similar articles

• Prolonged hepatitis C virus seroconversion in a blood donor, detected by HCV antigen test in parallel with HCV RNA.

  Alvarez M, Planelles D, Vila E, Montoro J, Franco E. Alvarez M, et al. Vox Sang. 2004 May;86(4):266-7. doi: 10.1111/j.0042-9007.2004.00513.x. Vox Sang. 2004. PMID: 15144533 No abstract available.
• NAT yield for human immunodeficiency and hepatitis C viruses in Brazilian blood donors: preliminary results.

  Andrea P, Kupek E, Genovez G, Martins JT, Barban GB. Andrea P, et al. Transfus Med. 2015 Apr;25(2):125-7. doi: 10.1111/tme.12180. Epub 2015 Feb 26. Transfus Med. 2015. PMID: 25720742 No abstract available.
• [Planning and significance of tests to confrim the presence of anti-hepatitis-C antibodies in blood donors. Spanish Study Group for Blood Donors at Risk].

  León P, Echevarría JM. León P, et al. Sangre (Barc). 1999 Oct;44(5):309-14. Sangre (Barc). 1999. PMID: 10618905 Spanish. No abstract available.
• [Serological and molecular markers of HCV infection in Polish blood donors].

  Brojer E. Brojer E. Przegl Epidemiol. 2005;59(2):511-7. Przegl Epidemiol. 2005. PMID: 16190561 Review. Polish.
• Laboratory assays for diagnosis and management of hepatitis C virus infection.

  Richter SS. Richter SS. J Clin Microbiol. 2002 Dec;40(12):4407-12. doi: 10.1128/JCM.40.12.4407-4412.2002. J Clin Microbiol. 2002. PMID: 12454127 Free PMC article. Review. No abstract available.